Welcome to Multibagg AI
Log in to access personalized features
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stock
Sunil Healthcare Limited is a leading manufacturer of Empty Hard Gelatin Capsule Shells in India, known for high-quality production standards.
The company has expanded significantly since its inception, increasing its capsule production capacity to 15 billion shells annually by 2021-22.
Sunil Healthcare also ventured into the food business, under the 'Sunloc Foods' brand, focusing on nuts and edible items like cashews and pistachios.
The company has established subsidiaries in the USA and Mexico to extend its market reach and capitalize on international demand.
Sunil Healthcare's recognition as a 'Star Export House' by the government underscores its substantial export capabilities and market presence.
Pharmaceuticals & Biotechnology
Pharmaceuticals
81 Cr
Low Risk
22.6
37.7
1.1
1.5
86.79
56.35
Sales CAGR
Profit CAGR
ROE
ROCE
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Sunil Healthcare Ltd (SUNLOC) is currently trading at 76.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Sunil Healthcare Limited is a leading manufacturer of Empty Hard Gelatin Capsule Shells in India, known for high-quality production standards. The company has expanded significantly since its inception, increasing its capsule production capacity to 15 billion shells annually by 2021-22. Sunil Healthcare also ventured into the food business, under the 'Sunloc Foods' brand, focusing on nuts and edible items like cashews and pistachios. The company has established subsidiaries in the USA and Mexico to extend its market reach and capitalize on international demand. Sunil Healthcare's recognition as a 'Star Export House' by the government underscores its substantial export capabilities and market presence.
Over the past 52 weeks, Sunil Healthcare Ltd has traded between a low of ₹56.35 and a high of ₹86.79. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Sunil Healthcare Ltd has a market capitalization of approximately 80.50. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Sunil Healthcare Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 22.55 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 80.50 Cr, Sunil Healthcare Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Sunil Healthcare Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Sunil Healthcare Ltd is 22.55. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Bearish
2
Neutral
6
Bullish
6
Bearish
12
Neutral
6
Bullish
28
Bearish
10
Neutral
0
Bullish
22
Bearish
2
Neutral
6
Bullish
6
Bearish
2
Neutral
6
Bullish
6
Bearish
10
Neutral
0
Bullish
22
Bearish
10
Neutral
0
Bullish
22
Bearish
10
Neutral
0
Bullish
22
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
57.85 | 91 Cr | 47.21 | 3.21 | 0.00 | 6.80 | 10.18 | 5.52 | ||
761.00 | 91 Cr | 21.72 | 1.56 | 0.46 | 8.32 | 10.75 | 5.27 | ||
43.51 | 87 Cr | 7.62 | 1.08 | 1.15 | 14.17 | 19.07 | 13.18 | ||
76.00 | 81 Cr | 22.55 | 1.52 | 0.00 | 5.76 | 6.56 | 2.17 | ||
48.10 | 78 Cr | 8.35 | 1.25 | 0.00 | 15.41 | 18.92 | 6.93 | ||
37.09 | 71 Cr | 64.39 | 1.57 | 0.00 | 2.44 | 6.78 | 0.89 | ||
233.45 | 71 Cr | -32.27 | 1.05 | 0.00 | -4.86 | -2.57 | -1.78 | ||
| Median: 7 Co. | — | 57.85 | 81 Cr | 21.72 | 1.52 | 0.00 | 6.80 | 10.18 | 5.27 |
